Medtronic Leading with Evidence: Latest data from Evolut TAVI and Renal Denervation

Published: 18 Sep 2020

  • Views:

    Views Icon 1392
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Introduction and Learning Objectives – Jeffrey Popma, Boston, US
Paradigm Shifting Evidence in TAVI – Evolut Low Risk Trial and Sub Analyses – Jeffrey Popma, Boston, US 
The Importance of Valve Hemodynamics – Why Should it be a Priority in TAVI? – Mohamed Abdel-Wahab, Leipzig, DE 
A Pivotal Moment for Renal Denervation - Michael Boehm, Homburg/Saar, DE
Addressing the Population Question: Who is the Renal Denervation Patient?  – Atul Pathak, Monaco